Streptokinase ... never again

被引：2

作者：

Van de Werf, F ^{[1
]}

机构：

[1] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

来源：

EUROPEAN HEART JOURNAL | 1999年 / 20卷 / 17期

关键词：

D O I：

10.1053/euhj.1999.1644

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1215 / 1215

页数：1

共 5 条

[1] Engineered staphylokinase variants with reduced immunogenicity [J].

Collen, D .

FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 :59-65

[2] NEUTRALIZING ANTIBODIES TO STREPTOKINASE 4 YEARS AFTER INTRAVENOUS THROMBOLYTIC THERAPY [J].

ELLIOTT, JM ;

CROSS, DB ;

CEDERHOLMWILLIAMS, SA ;

WHITE, HD .

AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (08) :640-645

[3] Humoral and cellular immune responses up to 7•5 years after administration of streptokinase for acute myocardial infarction [J].

Squire, IB ;

Lawley, W ;

Fletcher, S ;

Holme, E ;

Hillis, WS ;

Hewitt, C ;

Woods, KL .

EUROPEAN HEART JOURNAL, 1999, 20 (17) :1245-1252

[4] A RANDOMIZED TRIAL OF RECOMBINANT STAPHYLOKINASE VERSUS ALTEPLASE FOR CORONARY-ARTERY PATENCY IN ACUTE MYOCARDIAL-INFARCTION [J].

VANDERSCHUEREN, S ;

BARRIOS, L ;

KERDSINCHAI, P ;

VANDENHEUVEL, P ;

HERMANS, L ;

VROLIX, M ;

DEMAN, F ;

BENIT, E ;

MUYLDERMANS, L ;

COLLEN, D ;

DEWERF, FV .

CIRCULATION, 1995, 92 (08) :2044-2049

[5]

VRANCHX P, 1997, CIRCULATION S8, V96, P261

← 1 →